Derek Chalmers
2015
In 2015, Derek Chalmers earned a total compensation of $1.8M as President and Chief Executive Officer at Cara Therapeutics, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $237,500 |
|---|---|
| Option Awards | $1,072,642 |
| Salary | $475,000 |
| Other | $7,950 |
| Total | $1,793,092 |
Chalmers received $1.1M in option awards, accounting for 60% of the total pay in 2015.
Chalmers also received $237.5K in non-equity incentive plan, $475K in salary and $8K in other compensation.
Rankings
In 2015, Derek Chalmers' compensation ranked 5,170th out of 13,638 executives tracked by ExecPay. In other words, Chalmers earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,170 out of 13,638 | 62nd |
Division Manufacturing | 1,910 out of 5,190 | 63rd |
Major group Chemicals And Allied Products | 691 out of 1,854 | 63rd |
Industry group Drugs | 549 out of 1,528 | 64th |
Industry Pharmaceutical Preparations | 433 out of 1,182 | 63rd |
Source: SEC filing on April 27, 2016.
Chalmers' colleagues
We found two more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2015.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019